MedTrace Logo

Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron Content

NCT02025543 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2025-08-12

No results posted yet for this study

Summary

The purpose of this multi-site research is to validate a rapid magnetic resonance based confounder-corrected R-2 mapping method as a quantitative imaging biomarker of liver iron concentrations.

Conditions

  • Iron Overload
  • Hemochromatosis
  • Hemosiderosis

Interventions

DEVICE

MRI

R2 MRI scan

Sponsors & Collaborators

  • Johns Hopkins University

    collaborator OTHER

  • Stanford University

    collaborator OTHER

  • University of Texas

    collaborator OTHER

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Scott Reeder · University of Wisconsin, Madison

Eligibility

Min Age
8 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-08-12
Primary Completion
2019-09-30
Completion
2019-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02025543 on ClinicalTrials.gov